[go: up one dir, main page]

ZA200703622B - Novel use of α-sympathomlmetics having a 2-imidazoline structure - Google Patents

Novel use of α-sympathomlmetics having a 2-imidazoline structure

Info

Publication number
ZA200703622B
ZA200703622B ZA200703622A ZA200703622A ZA200703622B ZA 200703622 B ZA200703622 B ZA 200703622B ZA 200703622 A ZA200703622 A ZA 200703622A ZA 200703622 A ZA200703622 A ZA 200703622A ZA 200703622 B ZA200703622 B ZA 200703622B
Authority
ZA
South Africa
Prior art keywords
sympathomlmetics
novel use
imidazoline structure
imidazoline
novel
Prior art date
Application number
ZA200703622A
Other languages
English (en)
Inventor
Sacher Fritz
Koelsch Stephan
Tschaikin Marion
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35276675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200703622(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA200703622B publication Critical patent/ZA200703622B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200703622A 2004-10-05 2007-05-04 Novel use of α-sympathomlmetics having a 2-imidazoline structure ZA200703622B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004049008A DE102004049008A1 (de) 2004-10-05 2004-10-05 Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur

Publications (1)

Publication Number Publication Date
ZA200703622B true ZA200703622B (en) 2008-08-27

Family

ID=35276675

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200703622A ZA200703622B (en) 2004-10-05 2007-05-04 Novel use of α-sympathomlmetics having a 2-imidazoline structure

Country Status (20)

Country Link
US (1) US20080108685A1 (xx)
EP (1) EP1802302B1 (xx)
JP (1) JP5311825B2 (xx)
KR (1) KR20070059134A (xx)
CN (1) CN101022797B (xx)
AU (1) AU2005291603B2 (xx)
BR (1) BRPI0516832A (xx)
CA (1) CA2582984C (xx)
CY (1) CY1118581T1 (xx)
DE (1) DE102004049008A1 (xx)
DK (1) DK1802302T3 (xx)
ES (1) ES2612544T3 (xx)
HU (1) HUE031515T2 (xx)
LT (1) LT1802302T (xx)
MX (1) MX2007004040A (xx)
PL (1) PL1802302T3 (xx)
PT (1) PT1802302T (xx)
RU (1) RU2397764C2 (xx)
WO (1) WO2006037452A1 (xx)
ZA (1) ZA200703622B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004049008A1 (de) 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
US12343427B1 (en) * 2024-04-23 2025-07-01 Nivagen Pharmaceuticals, Inc. Stable intravenous diltiazem hydrochloride formulation and use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2122719A1 (en) 1991-11-19 1993-05-27 Jack M. Gwaltney, Jr. Combined virustatic antimediator (covam) treatment of common colds
JPH06211659A (ja) * 1993-01-19 1994-08-02 Kowa Co 点鼻薬組成物
US5576437A (en) * 1993-12-17 1996-11-19 The Procter & Gamble Company 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
DE4438589A1 (de) 1994-10-28 1995-03-23 Reingard Dr Muenster Nasentherapeutikum
WO1996025163A1 (en) * 1995-02-14 1996-08-22 Board Of Supervisors Or Louisiana State Universityof Agricultural And Mechanical College Through Itsmedical Center Treatment of herpes simplex viruses
US5916900A (en) 1995-06-29 1999-06-29 The Procter & Gamble Company 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
DE19541919C2 (de) 1995-11-10 1997-11-20 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
EP1326642A2 (en) * 2000-09-29 2003-07-16 Board of Trustees operating Michigan State University Catecholamine pharmaceutical compositions and methods
EA008165B1 (ru) 2001-09-18 2007-04-27 Никомед Данмарк Апс Композиции для лечения простуды
RU2220739C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Интраназальное средство
DE10250944B9 (de) 2002-10-31 2004-09-16 Cell Center Cologne Gmbh Verwendung eines Stifts zur Applikation von Pflege- oder Wirkstoffen in die Nase
DE102004049008A1 (de) 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur

Also Published As

Publication number Publication date
PL1802302T3 (pl) 2017-08-31
LT1802302T (lt) 2017-02-10
RU2397764C2 (ru) 2010-08-27
CA2582984A1 (en) 2006-04-13
CA2582984C (en) 2012-06-05
PT1802302T (pt) 2017-02-07
CN101022797A (zh) 2007-08-22
JP2008515824A (ja) 2008-05-15
JP5311825B2 (ja) 2013-10-09
EP1802302B1 (de) 2016-10-26
MX2007004040A (es) 2007-05-24
CN101022797B (zh) 2010-12-15
BRPI0516832A (pt) 2008-09-23
WO2006037452A1 (de) 2006-04-13
DE102004049008A1 (de) 2006-04-06
EP1802302A1 (de) 2007-07-04
CY1118581T1 (el) 2017-07-12
AU2005291603A1 (en) 2006-04-13
AU2005291603B2 (en) 2010-10-14
US20080108685A1 (en) 2008-05-08
RU2007116719A (ru) 2008-11-20
HUE031515T2 (en) 2017-07-28
ES2612544T3 (es) 2017-05-17
KR20070059134A (ko) 2007-06-11
DK1802302T3 (en) 2017-02-06

Similar Documents

Publication Publication Date Title
HUE064615T2 (hu) Egy 4-oxokinolin-vegyület stabil kristályát tartalmazó kombináció
IL178029A0 (en) Use of sulfonylureas
GB0404124D0 (en) Antagonists of GIP
EP1804681A4 (en) ANNUAL ADHESIVE STRUCTURE
GB0504995D0 (en) Use of a compound
EP1806147A4 (en) USE OF IMMUNOSUPPRESSIVE RECEPTOR
GB0417587D0 (en) Conformable structures
ZA200703622B (en) Novel use of α-sympathomlmetics having a 2-imidazoline structure
PL1705998T3 (pl) Zastosowanie karboksypeptydazy
GB0410554D0 (en) A crutch
GB0711875D0 (en) Use of a cloth
AU158223S (en) Wristwatch
GB0424405D0 (en) A structure
EP1739134A4 (en) COMPOST AZO
AU157395S (en) A set of hangers
GB0427206D0 (en) A bath
GB2425472B (en) A shower construction
GB0522829D0 (en) Use of a compound
GB2416051B (en) Selection of component
AU156767S (en) A set of sinks
AU157010S (en) A set of street furniture
AU157009S (en) A set of street furniture
AU157008S (en) A set of street furniture
PL369353A1 (pl) Zestaw elementów budowlanych
PL371989A1 (pl) Zestaw elementów rurkowych